Connect with us

Health

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations – News-Medical.Net

Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by…

Published

on

post featured image

Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers.
The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine.
This study highlights the blind spot in how clinical trials are done in the United States. Researchers, hospitals and pharmaceutical…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending